NCT01713309View on ClinicalTrials.gov

Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 31, 1996

Primary Completion Date

June 30, 1998

Study Completion Date

September 30, 1998

Conditions
Acute Respiratory FailureCritically Ill
Interventions
DRUG

Filgrastim

Filgrastim 300 ug daily for 7 days, subcutaneously.

Trial Locations (1)

00029

Helsinki University Central Hospital, Helsinki

All Listed Sponsors
collaborator

The Swedish Research Council

OTHER_GOV

lead

Helsinki University Central Hospital

OTHER

NCT01713309 - Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim) | Biotech Hunter | Biotech Hunter